"By weaving his experiences with information on the rise of anti-science sentiment, how it was funneled into a movement, and how it has become a tool of far-right political figures around the world, the author opens readers' eyes to the dangerous world it creates. Even as he paints a picture of the world under a shadow of aggressive ignorance, he demonstrates his innate optimism, offering suggestions for how science denial can be met by other active scientists"--
Introduction to the Neglected Tropical Diseases: the Ancient Afflictions of Stigma and Poverty -- "The Unholy Trinity": the Soil-Transmitted Helminth Infections Ascariasis, Trichuriasis, and Hookworm Infection -- Schistosomiasis (Snail Fever) and the Food-borne Trematodiases -- Elephantiasis: Lymphatic Filariasis, Endemic Nonfilarial Elephantiasis (Podoconiosis), and Dracunculiasis (Guinea Worm) -- The Blinding Neglected Tropical Diseases: Onchocerciasis (River Blindness) and Trachoma -- The Mycobacterial Infections: Buruli Ulcer and Leprosy -- The Kinetoplastid Infections: Human African Trypanosomiasis (Sleeping Sickness), American Trypanosomiasis (Chagas Disease), and the Leishmaniases -- The Urban Neglected Tropical Diseases: Leptospirosis, Dengue and Zika, and Rabies -- The Neglected Tropical Diseases of North America -- Uniting to Combat Neglected Tropical Diseases, and a New WHO Roadmap (2021-2030) -- Future Trends in Control of Neglected Tropical Diseases and the Antipoverty Vaccines -- The Newest NTDs and a Plea to "Repair the World" -- Appendix: What Are the Neglected Tropical Diseases?
Access options:
The following links lead to the full text from the respective local libraries:
A New Post-2015 Urgency -- A Cold War Legacy -- Vaccine Science Envoy -- Battling Diseases of the Anthropocene -- The Middle East Killing Fields -- Africa's "Un-Wars" -- The Northern Triangle and Collapse of Venezuela -- Sorting It Out : Attributable Risks -- Global Health Security and the Rise in Antiscience -- Implementing Vaccine Diplomacy and the Rise of COVID -- The Broken Obelisk.
Cover -- Half-title -- Title -- Copyright -- Contents -- Foreword -- Preface -- Introduction -- 1 A Changing Landscape in Global Health -- 2 The "Other Diseases": The Neglected Tropical Diseases -- 3 Introducing Blue Marble Health -- 4 East Asia: China, Indonesia, Japan, and South Korea -- 5 India -- 6 Sub-Saharan Africa: Nigeria and South Africa -- 7 Saudi Arabia and Neighboring Conflict Zones of the Middle East and North African Region -- 8 The Americas: Argentina, Brazil, and Mexico -- 9 Australia, Canada, European Union, Russian Federation, and Turkey -- 10 United States of America
Access options:
The following links lead to the full text from the respective local libraries:
Huang zhong bing, the "yellow puffy disease" caused by parasitic hookworms living in the human small intestine, was common throughout pre-liberation China. Hookworms contributed significantly to the nation's reputation as the sick man of Asia. However, even today China has the world's greatest number of cases of human hookworm infection. From estimates based on diagnostic surveys obtained during the early 1990s on over one million patients, there are approximately 194 million Chinese infected with hookworm. Most of these infections occur among the rural poor in the south and south-west. Even more recent data obtained in 1997 and 1998 indicate that hookworm remains a major public health problem in Hainan, Sichuan and Yunnan provinces. Populations of the elderly and middle-aged women are emerging as the groups now at greatest risk for acquiring hookworm. New evidence indicates that in addition to threatening health, hookworms also contribute significantly to economic under-development. Hookworms are a living reminder of China's often-forgotten rural southern poverty and a rapidly growing urban–rural inequality; they are an impediment to China's future economic growth.
More than 100 million people are facing a return to extreme poverty because of coronavirus disease 2019 (COVID-19), while new estimates suggest that three nations—India, Nigeria, and the Democratic Republic of the Congo—may suffer the greatest economic contractions. Such findings will have profound consequences in terms of our ability to control or eliminate the most widely prevalent neglected tropical diseases
When it emerged in late 2019, COVID-19 was carried via travelers to Germany, France and Italy, where freedom of movement accelerated its transmission throughout Europe. However, effective non-pharmaceutical interventions introduced by European governments led to containment of the rapid increase in cases within European nations. Electronic searches were performed to obtain the number of confirmed cases, incident rates and non-pharmaceutical government measures for each European country. The spread and impact of non-pharmaceutical interventions throughout Europe were assessed and visualized. Specifically, heatmaps were used to represent the number of confirmed cases and incident rates for each of the countries over time. In addition, maps were created showing the number of confirmed cases and incident rates in Europe on three different dates (15 March, 15 April and 15 May 2020), which allowed us to assess the geographic and temporal patterns of the disease.
When it emerged in late 2019, COVID-19 was carried via travelers to Germany, France and Italy, where freedom of movement accelerated its transmission throughout Europe. However, effective non-pharmaceutical interventions introduced by European governments led to containment of the rapid increase in cases within European nations. Electronic searches were performed to obtain the number of confirmed cases, incident rates and non-pharmaceutical government measures for each European country. The spread and impact of non-pharmaceutical interventions throughout Europe were assessed and visualized. Specifically, heatmaps were used to represent the number of confirmed cases and incident rates for each of the countries over time. In addition, maps were created showing the number of confirmed cases and incident rates in Europe on three different dates (15 March, 15 April and 15 May 2020), which allowed us to assess the geographic and temporal patterns of the disease. ; We acknowledge Umm Al Qura University for their support and encouragement.
Poverty remains the overriding social determinant for the neglected tropical diseases (NTDs), but over the last several decades, we have also seen how political destabilization or even outright conflict can hasten economic declines and promote a substantial uptick in NTD incidence and prevalence [1]. Recent examples include the emergence of Ebola virus infection in West Africa [2], visceral leishmaniasis and other NTDs in East Africa [3, 4], and cutaneous leishmaniasis in the Middle East and North Africa [5], as well as guerilla activities linked to the drug trade in Latin America [6]. Vector-borne (taken here to encompass diseases transmitted by arthropods or snails) and zoonotic NTDs have been disproportionately represented among these emerging or reemerging infections.
OBJECTIVE: To examine the current partnerships to improve the childhood immunisation programme in the Democratic Peoples' Republic of Korea (DPRK) in the context of the political determinants of health equity. METHODS: A literature search was conducted to identify public health collaborations with the DPRK government. Based on the amount of publicly accessible data and a shared approach in health system strengthening among the partners in immunisation programmes, the search focused on these partnerships. RESULTS: The efforts by WHO, UNICEF, GAVI and IVI with the DPRK government improved the delivery of childhood vaccines (e.g. pentavalent vaccines, inactivated polio vaccine, two-dose measles vaccine and Japanese encephalitis vaccine) and strengthened the DPRK health system by equipping health centres, and training all levels of public health personnel for VPD surveillance and immunisation service delivery. CONCLUSION: The VPD-focused programmatic activities in the DPRK have improved the delivery of childhood immunisation and have created dialogue and contact with the people of the DPRK. These efforts are likely to ameliorate the political isolation of the people of the DPRK and potentially improve global health equity.
Introduction: Chagas disease, caused by infection with the parasite Trypanosoma cruzi, represents a huge public health problem in the Americas, where millions of people are affected. Despite the availability of two drugs against the infection (benznidazole and nifurtimox), multiple factors impede their effective usage: (1) gaps in patient and healthcare provider awareness; (2) lack of access to diagnosis; (3) drug toxicity and absence of treatment algorithms to address adverse effects; (4) failures in drug supply and distribution; and (5) inconsistent drug efficacy against the symptomatic chronic stage. Areas covered: We review new approaches and technologies to enhance access to diagnosis and treatment to reduce the disease burden. We also provide an updated picture of recently published and ongoing anti-T. cruzi drug clinical trials. Although there has been progress improving the research and development (R&D) landscape, it is unclear whether any new treatments will emerge soon. Literature search methodologies included multiple queries to public databases and the use of own-built libraries. Expert opinion: Besides R&D, there is a major need to continue awareness and advocacy efforts by patient associations, local and national governments, and international agencies. Overall, health systems strengthening is essential to ensure vector control commitments, as well as patient access to diagnosis and treatment.
